Ian Fier insider trades: Momenta Pharmaceuticals (MNTA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ian reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2020 | MNTA | ↓ Sell | 1,808 | $52.17 | $94K | Direct | Aug 21, 2020 (1d) |
| Aug 10, 2020 | MNTA | ↓ Sell | 330 | $32.36 | $11K | Direct | Aug 11, 2020 (1d) |
| Aug 4, 2020 | MNTA | ↓ Sell | 24,969 | $32.76 | $818K | Direct | Aug 6, 2020 (2d) |
| Jul 22, 2020 | MNTA | ↓ Sell | 33,504 | $32.48 | $1.1M | Direct | Jul 23, 2020 (1d) |
| Jul 20, 2020 | MNTA | ↓ Sell | 1,087 | $33.95 | $37K | Direct | Jul 21, 2020 (1d) |
| Jun 30, 2020 | MNTA | ↓ Sell | 6,811 | $35.10 | $239K | Direct | Jul 1, 2020 (1d) |
| Jun 12, 2020 | MNTA | ↓ Sell | 6,756 | $30.15 | $204K | Direct | Jun 15, 2020 (3d) |
| May 20, 2020 | MNTA | ↓ Sell | 1,818 | $31.06 | $56K | Direct | May 21, 2020 (1d) |
| May 8, 2020 | MNTA | ↓ Sell | 319 | $33.30 | $11K | Direct | May 11, 2020 (3d) |
| Apr 22, 2020 | MNTA | ↓ Sell | 1,314 | $31.11 | $41K | Direct | Apr 24, 2020 (2d) |
| Apr 20, 2020 | MNTA | ↓ Sell | 1,124 | $28.97 | $33K | Direct | Apr 21, 2020 (1d) |
| Mar 6, 2020 | MNTA | ↓ Sell | 7,310 | $29.00 | $212K | Direct | Mar 9, 2020 (3d) |
| Feb 20, 2020 | MNTA | ↓ Sell | 15,931 | $33.37 | $532K | Direct | Feb 24, 2020 (4d) |
| Feb 13, 2020 | MNTA | ↓ Sell | 6,689 | $30.03 | $201K | Direct | Feb 14, 2020 (1d) |
| Feb 11, 2020 | MNTA | ↓ Sell | 350 | $32.23 | $11K | Direct | Feb 12, 2020 (1d) |
| Feb 10, 2020 | MNTA | ↓ Sell | 213 | $31.50 | $7K | Direct | Feb 11, 2020 (1d) |
| Jan 22, 2020 | MNTA | ↓ Sell | 1,577 | $28.98 | $46K | Direct | Jan 24, 2020 (2d) |
| Jan 21, 2020 | MNTA | ↓ Sell | 860 | $30.08 | $26K | Direct | Jan 22, 2020 (1d) |
| Jan 14, 2020 | MNTA | ↓ Sell | 87,703 | $23.58 | $2.1M | Direct | Jan 16, 2020 (2d) |
| Dec 24, 2019 | MNTA | ↓ Sell | 39,133 | $20.00 | $783K | Direct | Dec 27, 2019 (3d) |
| Nov 12, 2019 | MNTA | ↓ Sell | 529 | $16.18 | $9K | Direct | Nov 13, 2019 (1d) |
| Nov 8, 2019 | MNTA | ↓ Sell | 320 | $16.06 | $5K | Direct | Nov 12, 2019 (4d) |
| Oct 21, 2019 | MNTA | ↓ Sell | 5,770 | $14.40 | $83K | Direct | Oct 23, 2019 (2d) |
| Oct 18, 2019 | MNTA | ↓ Sell | 3,980 | $13.83 | $55K | Direct | Oct 21, 2019 (3d) |
| Aug 12, 2019 | MNTA | ↓ Sell | 354 | $11.64 | $4K | Direct | Aug 13, 2019 (1d) |
| Aug 8, 2019 | MNTA | ↓ Sell | 210 | $11.82 | $2K | Direct | Aug 9, 2019 (1d) |
| May 10, 2019 | MNTA | ↓ Sell | 354 | $14.00 | $5K | Direct | May 14, 2019 (4d) |
| May 8, 2019 | MNTA | ↓ Sell | 213 | $13.68 | $3K | Direct | May 9, 2019 (1d) |
| Apr 29, 2019 | MNTA | ↓ Sell | 38,677 | $15.00 | $580K | Direct | May 1, 2019 (2d) |
| Apr 9, 2019 | MNTA | ↓ Sell | 4,163 | $15.00 | $62K | Direct | Apr 11, 2019 (2d) |
| Mar 15, 2019 | MNTA | ↓ Sell | 10,000 | $13.92 | $139K | Direct | Mar 19, 2019 (4d) |
| Feb 20, 2019 | MNTA | ↓ Sell | 351 | $14.05 | $5K | Direct | Feb 22, 2019 (2d) |
| Feb 14, 2019 | MNTA | ↓ Sell | 4,450 | $13.10 | $58K | Direct | Feb 19, 2019 (5d) |
| Feb 13, 2019 | MNTA | ↓ Sell | 5,453 | $12.70 | $69K | Direct | Feb 14, 2019 (1d) |
| Feb 12, 2019 | MNTA | ↓ Sell | 414 | $12.77 | $5K | Direct | Feb 13, 2019 (1d) |
| Feb 8, 2019 | MNTA | ↓ Sell | 251 | $11.52 | $3K | Direct | Feb 11, 2019 (3d) |
| Nov 20, 2018 | MNTA | ↓ Sell | 355 | $12.30 | $4K | Direct | Nov 21, 2018 (1d) |
| Nov 12, 2018 | MNTA | ↓ Sell | 352 | $13.15 | $5K | Direct | Nov 14, 2018 (2d) |
| Nov 8, 2018 | MNTA | ↓ Sell | 218 | $14.09 | $3K | Direct | Nov 13, 2018 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ian Fier's insider trades
Ian Fier is Chief Mfg and Program Officer at Momenta Pharmaceuticals (MNTA). Since Nov 8, 2018, Ian has reported no open-market purchases and 39 sales worth $7.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (21 filings), grants and awards (6 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.